175
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma

, ORCID Icon, , ORCID Icon, , & show all
Pages 810-815 | Received 05 Apr 2019, Accepted 17 May 2019, Published online: 05 Jul 2019

References

  • Ferlito A, Shaha AR, Silver CE, et al. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63:202–207.
  • Wiegand S, Zimmermann A, Wilhelm T, et al. Survival after distant metastasis in head and neck cancer. Anticancer Res. 2015;35:5499–5502.
  • Suh JD, Cho JH. Trends in head and neck cancer in South Korea between 1999 and 2012. Clin Exp Otorhinolaryngol. 2016;9:263–269.
  • Evangelista L, Cervino AR, Chondrogiannis S, et al. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview. Nucl Med Commun. 2014;35:123–134.
  • Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med. 1991;32:1548–1555.
  • Kim JW, Oh JS, Roh JL, et al. Prognostic significance of standardized uptake value and metabolic tumour volume on (1)(8)F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2015;42:1353–1361.
  • Pelosi E, Messa C, Sironi S, et al. Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging. 2004;31:932–939.
  • Yi JS, Kim JS, Lee JH, et al. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. J Surg Oncol. 2012;106:708–712.
  • Chong A, Ha JM, Han YH, et al. Preoperative lymph node staging by FDG PET/CT with contrast enhancement for thyroid cancer: a multicenter study and comparison with neck CT. Clin Exp Otorhinolaryngol. 2017;10:121–128.
  • Paidpally V, Chirindel A, Chung CH, et al. FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol. 2014;203:W139–W145.
  • Manca G, Vanzi E, Rubello D, et al. (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications. Eur J Nucl Med Mol Imaging. 2016;43:1360–1375.
  • Ahn SH, Hong HJ, Kwon SY, et al. Guidelines for the surgical management of laryngeal cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol. 2017;10:1–43.
  • Kim BH, Park SJ, Jeong WJ, et al. Comparison of treatment outcomes for T3 glottic squamous cell carcinoma: a meta-analysis. Clin Exp Otorhinolaryngol. 2018;11:1–8.
  • Denaro N, Merlano MC. Immunotherapy in head and neck squamous cell cancer. Clin Exp Otorhinolaryngol. 2018;11:217–223.
  • Denaro N, Merlano MC, Russi EG. Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol. 2016;9:287–297.
  • Perlow A, Bui C, Shreve P, et al. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr. 2004;28:704–709.
  • Kim SY, Roh JL, Yeo NK, et al. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol. 2007;18:1698–1703.
  • Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol. 2011;47:560–565.
  • Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65–72.
  • Schoder H, Fury M, Lee N, et al. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50 Suppl 1:74S–88S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.